ZHANG, X. et al. Laboratory Biomarkers and Immunological Modulation of Sintilimab in Gastric Cancer: A Meta-Analysis Focused on Tumor Markers and T-Cell Subsets: Sintilimab for Gastric Cancer: Efficacy, Markers, and Safety. Journal of Medical Biochemistry, v. 44, n. 6, p. 1171–1182, 10 July2025.